| Group A | Group B | Group C | P |
---|---|---|---|---|
Duration of clinical follow-up (months) | 45.4 ± 5.8 | 35.5 ± 13.0 | 21.1 ± 4.4 | 0.000 |
Pre-VAS score | 3.7 ± 3.2 | 4.1 ± 2.6 | 4.5 ± 2.7 | 0.721 |
Post-VAS score | 1.3 ± 1.6 | 1.8 ± 1.9 | 1.8 ± 1.5 | 0.564 |
∆VAS score (%) | 66.3 ± 32.7 | 30.4 ± 83.6 | 42.7 ± 48.0 | 0.311 |
Pre-JOA score | 12.6 ± 2.6 | 12.3 ± 1.7 | 12.2 ± 2.9 | 0.900 |
Post-JOA score | 14.2 ± 2.3 | 13.8 ± 2.2 | 13.9 ± 2.9 | 0.868 |
∆JOA score (%) | 28.8 ± 57.3 | 22.0 ± 61.0 | 30.3 ± 35.9 | 0.898 |
Pre-NDI score | 31.0 ± 13.7 | 33.4 ± 18.0 | 36.1 ± 16.0 | 0.651 |
Post-NDI score | 13.7 ± 11.1 | 17.8 ± 18.1 | 18.5 ± 13.9 | 0.593 |
∆NDI score (%) | 17.2 ± 16.5 | 15.7 ± 22.8 | 17.6 ± 20.2 | 0.958 |
Odom's criteria | Â | Â | Â | Â |
 excellent or good | 14(77.8%) | 8(50.0%) | 10(66.7%) | 0.255 |
 satisfactory | 2(11.1%) | 3(18.8%) | 2(13.3%) |  |
 bad | 2(11.1%) | 5(31.3%) | 3(20.0%) |  |